Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Shouldn't Require Monitoring Of Third Parties In REMS, Industry Says

Executive Summary

FDA's requirements for Risk Evaluation and Mitigation Strategies should focus on sponsors' activities and not the behavior of third parties, industry tells the agency in comments on a draft guidance

You may also be interested in...



With FDA's REMS Staff Overloaded, Final Guidance Could See Further Delays

The Risk Evaluation and Mitigation Strategy guidance, which has been under construction by FDA for more than a year, could see further delays before it is finalized

With FDA's REMS Staff Overloaded, Final Guidance Could See Further Delays

The Risk Evaluation and Mitigation Strategy guidance, which has been under construction by FDA for more than a year, could see further delays before it is finalized

Generics Should Get REMS Exemption For Sample Collection, GPhA Says

FDA should create a system to allow generic firms that want to develop ANDAs for products in closed distribution systems to obtain samples from the brand sponsors, the Generic Pharmaceutical Association says

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051845

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel